EE9900595A - Spetsiifilise 5-HT 2A-retseptori antagonisti kasutamine une hingamishäirete raviks kasulike ravimite valmistamiseks - Google Patents

Spetsiifilise 5-HT 2A-retseptori antagonisti kasutamine une hingamishäirete raviks kasulike ravimite valmistamiseks

Info

Publication number
EE9900595A
EE9900595A EEP199900595A EEP9900595A EE9900595A EE 9900595 A EE9900595 A EE 9900595A EE P199900595 A EEP199900595 A EE P199900595A EE P9900595 A EEP9900595 A EE P9900595A EE 9900595 A EE9900595 A EE 9900595A
Authority
EE
Estonia
Prior art keywords
preparation
treatment
specific
receptor antagonist
respiratory disorders
Prior art date
Application number
EEP199900595A
Other languages
English (en)
Estonian (et)
Inventor
Cattelin Fran�oise
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE9900595A publication Critical patent/EE9900595A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EEP199900595A 1997-06-26 1998-06-02 Spetsiifilise 5-HT 2A-retseptori antagonisti kasutamine une hingamishäirete raviks kasulike ravimite valmistamiseks EE9900595A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707998A FR2765107B1 (fr) 1997-06-26 1997-06-26 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
PCT/FR1998/001100 WO1999000119A1 (fr) 1997-06-26 1998-06-02 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil

Publications (1)

Publication Number Publication Date
EE9900595A true EE9900595A (et) 2000-08-15

Family

ID=9508467

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900595A EE9900595A (et) 1997-06-26 1998-06-02 Spetsiifilise 5-HT 2A-retseptori antagonisti kasutamine une hingamishäirete raviks kasulike ravimite valmistamiseks

Country Status (29)

Country Link
US (1) US6143792A (xx)
EP (1) EP1014960B1 (xx)
JP (1) JP3503953B2 (xx)
KR (1) KR20010014186A (xx)
CN (1) CN1154485C (xx)
AT (1) ATE232094T1 (xx)
AU (1) AU728227B2 (xx)
BG (1) BG104038A (xx)
BR (1) BR9810337A (xx)
CA (1) CA2295119C (xx)
CZ (1) CZ291935B6 (xx)
DE (1) DE69811248T2 (xx)
EE (1) EE9900595A (xx)
ES (1) ES2191942T3 (xx)
FR (1) FR2765107B1 (xx)
HK (1) HK1028351A1 (xx)
HU (1) HU229058B1 (xx)
ID (1) ID23799A (xx)
IL (1) IL133632A (xx)
IS (1) IS2356B (xx)
NO (1) NO325520B1 (xx)
NZ (1) NZ502495A (xx)
PL (1) PL190723B1 (xx)
RU (1) RU2218917C2 (xx)
SK (1) SK283845B6 (xx)
TR (1) TR199903197T2 (xx)
TW (1) TW580386B (xx)
UA (1) UA59397C2 (xx)
WO (1) WO1999000119A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
PT1066036E (pt) * 1998-02-27 2006-09-29 Univ Illinois Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
FR2787328A1 (fr) * 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
US6548082B1 (en) * 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
CN1305871C (zh) * 2002-07-19 2007-03-21 比奥维特罗姆股份公司 用于治疗与5－ht2a受体有关疾病的新哌嗪基－吡嗪酮衍生物
CA2590802A1 (en) 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
EP2186511A1 (en) * 2008-11-13 2010-05-19 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
EP2365805A1 (en) * 2008-11-13 2011-09-21 Sanofi Method of treating sleep disorders using eplivanserin
EP2266554A1 (en) * 2009-05-26 2010-12-29 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
EP2255726A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA912278B (en) * 1990-03-29 1992-11-25 Lilly Co Eli Compounds affecting serotonin receptors
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
BR9810337A (pt) 2000-09-05
ID23799A (id) 2000-05-11
NO996442L (no) 2000-02-28
ATE232094T1 (de) 2003-02-15
CN1154485C (zh) 2004-06-23
HU229058B1 (en) 2013-07-29
PL190723B1 (pl) 2005-12-30
ES2191942T3 (es) 2003-09-16
TW580386B (en) 2004-03-21
HK1028351A1 (en) 2001-02-16
NO325520B1 (no) 2008-06-02
EP1014960B1 (fr) 2003-02-05
EP1014960A1 (fr) 2000-07-05
AU728227B2 (en) 2001-01-04
US6143792A (en) 2000-11-07
SK283845B6 (sk) 2004-03-02
CN1265586A (zh) 2000-09-06
JP3503953B2 (ja) 2004-03-08
IL133632A (en) 2003-10-31
JP2001520678A (ja) 2001-10-30
TR199903197T2 (xx) 2000-05-22
NZ502495A (en) 2000-10-27
FR2765107A1 (fr) 1998-12-31
AU8024398A (en) 1999-01-19
DE69811248T2 (de) 2003-12-04
CA2295119A1 (en) 1999-01-07
CZ291935B6 (cs) 2003-06-18
IS2356B (is) 2008-04-15
HUP0002170A2 (hu) 2001-11-28
SK184599A3 (en) 2000-06-12
NO996442D0 (no) 1999-12-23
KR20010014186A (ko) 2001-02-26
WO1999000119A1 (fr) 1999-01-07
FR2765107B1 (fr) 2000-03-24
UA59397C2 (uk) 2003-09-15
BG104038A (en) 2001-04-30
IL133632A0 (en) 2001-04-30
IS5316A (is) 1999-12-21
HUP0002170A3 (en) 2001-12-28
DE69811248D1 (de) 2003-03-13
PL337871A1 (en) 2000-09-11
CZ469599A3 (cs) 2000-04-12
CA2295119C (en) 2007-02-13
RU2218917C2 (ru) 2003-12-20

Similar Documents

Publication Publication Date Title
EE9900595A (et) Spetsiifilise 5-HT 2A-retseptori antagonisti kasutamine une hingamishäirete raviks kasulike ravimite valmistamiseks
DE69400435D1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
AP2000001785A0 (en) Medicaments
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
DE60234616D1 (de) Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
DE69930308D1 (de) Selektive 5-ht 6-rezeptor-liganden
SE9702651D0 (sv) Novel compounds
HUP0401805A2 (hu) Pulmonális betegségek kezelésére szolgáló vegyületek
BG105962A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
MXPA01006319A (es) Uso de los antagonistas del receptor para 5ht, para el tratamiento de sindrome de fatiga cronica.
IL143143A0 (en) USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS
BR0314945A (pt) Uso de antagonistas de receptor 5-ht2 para tratamento de distúrbios de sono